https://www.cancer.gov/ The latest cancer news from the U.S. government's principal agency for cancer research. en https://www.cancer.gov/news-events/press-releases/2025/new-tissue-biomarker-for-aggressive-breast-cancer https://www.cancer.gov/news-events/press-releases/2025/new-tissue-biomarker-for-aggressive-breast-cancer Wed, 14 May 2025 12:00:00 +0000 A series of tissue changes may be associated with an increased risk of developing aggressive breast cancer among women with benign breast disease, and poorer rates of survival among women with invasive breast cancer. https://www.cancer.gov/news-events/press-releases/2025/early-onset-cancer-rates https://www.cancer.gov/news-events/press-releases/2025/early-onset-cancer-rates Thu, 08 May 2025 12:00:00 +0000 From 2010 through 2019, the incidence of 14 cancer types rose among people under age 50. However, the incidence of 19 other cancer types has decreased among this population. https://www.cancer.gov/news-events/press-releases/2025/annual-report-to-the-nation https://www.cancer.gov/news-events/press-releases/2025/annual-report-to-the-nation Mon, 21 Apr 2025 12:00:00 +0000 Overall death rates from cancer declined steadily among men and women from 2001 through 2022, even during the first two years of the COVID-19 pandemic, according to the 2024 Annual Report to the Nation on the Status of Cancer. https://www.cancer.gov/news-events/press-releases/2025/combination-immunotherapy-shrinks-solid-tumors https://www.cancer.gov/news-events/press-releases/2025/combination-immunotherapy-shrinks-solid-tumors Tue, 01 Apr 2025 12:00:00 +0000 A new form of personalized cancer immunotherapy, known as tumor infiltrating lymphocyte (TIL) therapy, dramatically improved the treatment’s effectiveness in patients with metastatic gastrointestinal cancers. https://www.cancer.gov/news-events/press-releases/2025/light-intensity-physical-activity-cancer-risk https://www.cancer.gov/news-events/press-releases/2025/light-intensity-physical-activity-cancer-risk Wed, 26 Mar 2025 12:00:00 +0000 A study of 85,000 older adults in the U.K. suggests that light- and moderate-to-vigorous-intensity daily physical activity can reduce cancer risk. The number of steps taken daily may be more important for cancer risk than the intensity of activity, the study shows. https://www.cancer.gov/news-events/press-releases/2025/gene-therapy-hpv-respiratory-papillomatosis https://www.cancer.gov/news-events/press-releases/2025/gene-therapy-hpv-respiratory-papillomatosis Thu, 13 Feb 2025 12:00:00 +0000 An NCI clinical trial showed that an experimental gene therapy called PRGN-2012 may be an effective treatment for recurrent respiratory papillomatosis, which is caused by HPV 6 and HPV 11. https://www.cancer.gov/news-events/press-releases/2024/cancer-deaths-averted-prevention-screening-contribution https://www.cancer.gov/news-events/press-releases/2024/cancer-deaths-averted-prevention-screening-contribution Thu, 05 Dec 2024 12:00:00 +0000 Over the past 45 years, the majority of deaths averted from breast, cervical, colorectal, lung, and prostate cancer were due to prevention and screening, rather than treatment advances, NCI researchers have found. https://www.cancer.gov/news-events/press-releases/2024/mutant-ras-proteins-new-role-in-cancer https://www.cancer.gov/news-events/press-releases/2024/mutant-ras-proteins-new-role-in-cancer Mon, 11 Nov 2024 12:00:00 +0000 A new study led by NCI researchers shows that mutant RAS proteins help release a nuclear protein from a complex transported from the nucleus to the cytoplasm, kicking off a series of events that lead to the breakdown of a tumor suppressor protein. https://www.cancer.gov/news-events/press-releases/2024/new-studies-from-human-tumor-atlas-network https://www.cancer.gov/news-events/press-releases/2024/new-studies-from-human-tumor-atlas-network Wed, 30 Oct 2024 12:00:00 +0000 New studies released by NCI’s Human Tumor Atlas Network explore the role of the tumor microenvironment and the immune system in promoting the spread of cancer and its resistance to treatment. The studies appear across several Nature journals. https://www.cancer.gov/news-events/press-releases/2024/myelomatch-precision-medicine-treatment-trial-launch https://www.cancer.gov/news-events/press-releases/2024/myelomatch-precision-medicine-treatment-trial-launch Wed, 23 Oct 2024 12:00:00 +0000 NCI has launched myeloMATCH, a precision medicine treatment trial that will test treatment combinations targeting specific genetic changes in people with acute myeloid leukemia and myelodysplastic syndromes.